EMA Authorised: Cubicin (daptomycin)

View source ↗

Summary

The European Medicines Agency authorised Cubicin (daptomycin) for Gram-positive bacterial infections including bacteremia, soft tissue infections, and bacterial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bacterial Endocarditis
• Soft Tissue Infection

Drugs mentioned

• Cubicin (daptomycin)

Snippet

Status: Authorised. Therapeutic area: Gram-Positive Bacterial Infections;Bacteremia;Soft Tissue Infections;Endocarditis, Bacterial. Decision date: 07/11/2025